Utilising pharmacy students to extend academic detailing services focused on naloxone and opioid overdose education


  • Lauren Linder Department of Medicine, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States
  • Megan Pruitt Department of Medicine, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States
  • Sarah Ball Department of Medicine, College of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States
  • Christopher Wisniewski Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, United States
  • Elizabeth Weed Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, United States




Academic detailing, Community pharmacist, Experiential education, Naloxone, Opioid overdose, Pharmacy student


Background: Academic detailing (AD) visits with community pharmacists can effectively increase naloxone access. Pharmacy students, introduced to AD principles, engage pharmacists in guided conversations on naloxone, expanding access and existing AD services. This report outlines an educational initiative to expand an existing AD service to community-based pharmacies.

Methods: Seventy-one first-year pharmacy students attended two virtual AD principles and naloxone training sessions. Students were subsequently required to have a guided conversation with their preceptor on offering naloxone and overdose education and complete an anonymous post-visit survey on their experience, understanding of current practice, and pharmacist-intended behaviour change.

Results: Fifty-two self-reported student surveys were assessed. Responses indicated that the following percentages of students believed their preceptor would: (1) start providing opioid overdose education to patients (42%; n=22/52), (2) demonstrate proper use of naloxone to patients at the time of naloxone dispensation (23%; n=12/52), (3) dispense naloxone without a prescription (17%; n=9/52), and (4) keep naloxone in stock (10%; n=5/52). The majority (81%; n=42/52) of students found this experience beneficial, and 69% (n=36/52) indicated they would like to participate in educational outreach again.

Conclusion: An innovative pharmacy student initiative allowed an AD service to extend face-to-face outreach to community pharmacists and promote the expansion of naloxone and opioid overdose education.


Appaneal, H. J., Lesniak, K., LaPlante, K. L., & Feret, B. (2023). Student pharmacists delivering academic detailing on adult pneumococcal vaccination to community pharmacists. Journal of the American Pharmacists Association, 63(4), 1064–1069.e2. https://doi.org/10.1016/j.japh.2023.04.003

Avorn, J., & Soumerai, S. B. (1983). Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". The New England Journal of Medicine, 308(24), 1457–1463. https://doi.org/10.1056/NEJM198306163082406

Avorn, J. (2017). Academic detailing: "Marketing" the best evidence to clinicians. JAMA, 317(4), 361–362. https://doi.org/10.1001/jama.2016.16036

Ball, S. J., McCauley, J. A., Pruitt, M., Zhang, J., Marsden, J., Barth, K. S., Mauldin, P. D., Gebregziabher, M., & Moran, W. P. (2021). Academic detailing increases prescription drug monitoring program use among primary care practices. Journal of the American Pharmacists Association, 61(4), 418–424.e2. https://doi.org/10.1016/j.japh.2021.02.019

Coffin, P. O., Behar, E., Rowe, C., Santos, G. M., Coffa, D., Bald, M., & Vittinghoff, E. (2016). Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain. Annals of Internal Medicine, 165(4), 245–252. https://doi.org/10.7326/M15-2771

Davis, M. T., Bateman, B., & Avorn, J. (2017). Educational outreach to opioid prescribers: The case for academic detailing. Pain Physician, 20(2S), S147–S151. https://pubmed.ncbi.nlm.nih.gov/28226336/

DiPaula, B. A., Cooke, C. E., Boyle, C. J., & Love, R. C. (2022). Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction. Journal of the American Pharmacists Association, 62(1), 241–246. https://doi.org/10.1016/j.japh.2021.09.012

Evoy, K. E., Groff, L., Hill, L. G., Godinez, W., Gandhi, R., & Reveles, K. R. (2020). Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas. Journal of the American Pharmacists Association, 60(1), 81–86. https://doi.org/10.1016/j.japh.2019.09.007

Evoy, K. E., Hill, L. G., & Davis, C. S. (2021). Considering the potential benefits of Over-the-Counter naloxone. Integrated Pharmacy Research & Practice, 10, 13–21. https://doi.org/10.2147/IPRP.S244709

Heidenreich, P. A., Lin, S., Gholami, P., Moore, V. R., Burk, M. L., Glassman, P. A., Cunningham, F. E., & Sahay, A. (2021). Interventions to increase leukocyte testing during treatment with dimethyl fumarate. International Journal of Environmental Research and Public Health, 18(19), 10312. https://doi.org/10.3390/ijerph181910312

Kavanaugh, R., Yerks, M., Feldman, R., & Stanton, M. (2021). Combining simulated academic detailing with naloxone training to prepare student pharmacists for opioid risk mitigation strategies. Currents in Pharmacy Teaching & Learning, 13(12), 1679–1682. https://doi.org/10.1016/j.cptl.2021.09.030

Kennedy, A. G., Regier, L., & Fischer, M. A. (2021a). Educating community clinicians using principles of academic detailing in an evolving landscape. American Journal of Health-System Pharmacy, 78(1), 80–86. https://doi.org/10.1093/ajhp/zxaa351

Kennedy, A. G., Wood, M., Starecheski, G., Belcher, R., & Cote, E. (2021b). Academic detailing with ambulatory pharmacists to support naloxone counseling. Journal of the American Pharmacists Association, 61(3), e133–e137. https://doi.org/10.1016/j.japh.2021.01.031

Kilmartin, K. C., McCarty, E. J., Shubkin, C. D., & Holmes, A. V. (2020). Reducing outpatient infant blood draws with transcutaneous measurement of bilirubin. Pediatric Quality & Safety, 5(4), e335. https://doi.org/10.1097/pq9.0000000000000335

Larson, M. J., Browne, C., Nikitin, R. V., Wooten, N. R., Ball, S., Adams, R. S., & Barth, K. (2018). Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention. Substance Abuse, 39(2), 218–224. https://doi.org/10.1080/08897077.2018.1449175

Makarov, D. V., Ciprut, S., Kelly, M., Walter, D., Shedlin, M. G., Braithwaite, R. S., Tenner, C. T., Gold, H. T., Zeliadt, S., & Sherman, S. E. (2021). Protocol: A multi-modal, physician-centered intervention to improve guideline-concordant prostate cancer imaging. Trials, 22(1), 711. https://doi.org/10.1186/s13063-021-05645-3

May, F. W., Rowett, D. S., Gilbert, A. L., McNeece, J. I., & Hurley, E. (1999). Outcomes of an educational-outreach service for community medical practitioners: Non-steroidal anti-inflammatory drugs. The Medical Journal of Australia, 170(10), 471–474. https://doi.org/10.5694/j.1326-5377.1999.tb127846.x

McKeirnan, K. C., Colorafi, K., Panther, S. G., Potyk, D., & McCarthy, J. (2019). Provider education about pneumococcal vaccination practices for older adults. The Senior Care Pharmacist, 34(7), 432–438. https://doi.org/10.4140/TCP.n.2019.432

McKeirnan, K., Colorafi, K., Sun, Z., Daratha, K., Potyk, D., & McCarthy, J. (2021). Improving pneumococcal vaccination rates among rural older adults through academic detailing: Medicine, nursing and pharmacy partnership. Vaccines, 9(4), 317. https://doi.org/10.3390/vaccines9040317

Melaragni, F., Levy, C., Pedrazzi, J., & Andersen, M. (2019). Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses. Journal of the American Pharmacists Association, 59(4), 550–554.e2. https://doi.org/10.1016/j.japh.2019.04.012

Morley, C. P., Schad, L. A., Tumiel-Berhalter, L. M., Brady, L. A., Bentham, A., Vitale, K., Norton, A., Noronha, G., & Swanger, C. (2021). Improving cancer screening rates in primary care via practice facilitation and academic detailing: A multi-PBRN quality improvement project. Journal of Patient-Centered Research and Reviews, 8(4), 315–322. https://doi.org/10.17294/2330-0698.1855

O'Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A. D., Odgaard-Jensen, J., Kristoffersen, D. T., Forsetlund, L., Bainbridge, D., Freemantle, N., Davis, D. A., Haynes, R. B., & Harvey, E. L. (2007). Educational outreach visits: Effects on professional practice and health care outcomes. The Cochrane Database of Systematic Reviews, 4, CD000409. https://doi.org/10.1002/14651858.CD000409.pub2

PrescribeToPrevent. (n.d.). Retrieved March 9, 2020, from https://prescribetoprevent.org

SC Board of Medical Examiners/SC Board of Pharmacy (2016). The South Carolina Board Of Medical Examiners and The South Carolina Board Of Pharmacy’s Joint Protocol to initiate dispensing of naloxone HCL without a prescription. http://naloxonesavessc.org/wp-content/uploads/2018/11/Joint_Naloxone_Protocol.pdf

Smart, M. H., Mandava, M. R., Lee, T. A., & Pickard, A. S. (2021). Feasibility and acceptability of virtual academic detailing on opioid prescribing. International Journal of Medical Informatics, 147, 104365. https://doi.org/10.1016/j.ijmedinf.2020.104365

Smart, R., Pardo, B., & Davis, C. S. (2020). Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction (Abingdon, England), 116(1), 6–17. https://doi.org/10.1111/add.15163

Soumerai, S. B., & Avorn, J. (1990). Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA, 263(4), 549–556. https://doi.org/10.1001/jama.1990.03440040088034

Stop the Addiction Fatality Epidemic (SAFE) Project. (2023). State naloxone access rules and regulations. Retrieved December 20, 2023, from https://www.safeproject.us/naloxone-awareness-project/state-rules/

Substance Abuse and Mental Health Services Administration (SAMHSA) (2018). SAMHSA opioid overdose prevention toolkit. https://store.samhsa.gov/product/opioid-overdose-prevention-toolkit

Tadrous, M., Fung, K., Desveaux, L., Gomes, T., Taljaard, M., Grimshaw, J. M., Bell, C. M., & Ivers, N. M. (2020). Effect of academic detailing on promoting appropriate prescribing of antipsychotic medication in nursing homes: A cluster randomized clinical trial. JAMA network open, 3(5), e205724. https://doi.org/10.1001/jamanetworkopen.2020.5724

Tamburrano, A., Mellucci, C., Galletti, C., Vitale, D., Vallone, D., Barbara, A., Sguera, A., Zega, M., Damiani, G., & Laurenti, P. (2019). Improving nursing staff attitudes toward vaccinations through academic detailing: The HProImmune questionnaire as a tool for medical management. International Journal of Environmental Research and Public Health, 16(11), 2006. https://doi.org/10.3390/ijerph16112006

Tewell, R., Edgerton, L., & Kyle, E. (2018). Establishment of a pharmacist-led service for patients at high risk for opioid overdose. American Journal of Health-System Pharmacy, 75(6), 376–383. https://doi.org/10.2146/ajhp170294

The National Resource Center for Academic Detailing (NARCAD). (2017). Introductory guide to academic detailing. https://www.narcad.org/uploads/5/7/9/5/57955981/introductory_guide_to_ad.pdf

tipSC. (2020). Naloxone can save a life. Timely Information for Providers in South Carolina. https://schealthviz.sc.edu/Data/Sites/1/media/downloads/tipsc_resources/tipsc_mailer_v10_hyperlinks_%2002%20naloxone%20sp%20ed.pdf

Wahl, K. R., Woolf, B. L., Hoch, M. A., Zillich, A. J., & Hudmon, K. S. (2015). Promoting pharmacy-based referrals to the tobacco quitline: a pilot study of academic detailing administered by pharmacy students. Journal of Pharmacy Practice, 28(2), 162–165. https://doi.org/10.1177/0897190013515711

Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. https://doi.org/10.1136/bmj.f174

Werremeyer, A., Mosher, S., Eukel, H., Skoy, E., Steig, J., Frenzel, O., & Strand, M. A. (2021). Pharmacists' stigma toward patients engaged in opioid misuse: When "social distance" does not mean disease prevention. Substance Abuse, 42(4), 919–926. https://doi.org/10.1080/08897077.2021.1900988

Wheeler, E., Jones, T. S., Gilbert, M. K., Davidson, P. J., & Centers for Disease Control and Prevention (CDC) (2015). Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. Morbidity and Mortality Weekly Report (MMWR), 64(23), 631–635. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a2.htm




How to Cite

Linder, L., Pruitt, M., Ball, S., Wisniewski, C., & Weed, E. (2024). Utilising pharmacy students to extend academic detailing services focused on naloxone and opioid overdose education. Pharmacy Education, 24(1), p. 340–347. https://doi.org/10.46542/pe.2024.241.340347



Research Article